Elanco stock plummeted Thursday after the company announced a pair of delays and a surprise box warning for its new eczema treatment for dogs. ↑ X NOW PLAYING How To Sell Stocks: Long-Term Trend Lines The company now expects it eczema drug Zenrelia to gain Food and Drug Administration approval in the third quarter and […]